Multiple Sclerosis/ Demyelinating Disease

Citations 171-180 of 328 total displayed.

Past content (since Jan 1998):

Original Contributions
Bystander Modulation of Chemokine Receptor Expression on Peripheral Blood T Lymphocytes Mediated by Glatiramer Therapy

Rameeza Allie; Lina Hu; Katherine M. Mullen; Suhayl Dhib-Jalbut; Peter A. Calabresi
Arch Neurol 2005; 62: 889-894. [Abstract] [Full text] [PDF]  

Original Contributions
Axonal Injury and Overall Tissue Loss Are Not Related in Primary Progressive Multiple Sclerosis

Marco Rovaris; Antonio Gallo; Andrea Falini; Beatrice Benedetti; Paolo Rossi; Mauro Comola; Giuseppe Scotti; Giancarlo Comi; Massimo Filippi
Arch Neurol 2005; 62: 898-902. [Abstract] [Full text] [PDF]  

Neurological Reviews
Internuclear Ophthalmoplegia: Unusual Causes in 114 of 410 Patients

James R. Keane
Arch Neurol 2005; 62: 714-717. [Abstract] [Full text] [PDF]  

Original Contributions
Enhanced Benefit of Increasing Interferon Beta-1a Dose and Frequency in Relapsing Multiple Sclerosis: The EVIDENCE Study

Steven R. Schwid; John Thorpe; Mohammad Sharief; Magnhild Sandberg-Wollheim; Kottil Rammohan; Jeanette Wendt; Hillel Panitch; Douglas Goodin; David Li; Peter Chang; Gordon Francis; for the EVIDENCE (Evidence of Interferon Dose-Response: European North American Comparative Efficacy) Study Group and the University of British Columbia MS/MRI Research Group
Arch Neurol 2005; 62: 785-792. [Abstract] [Full text] [PDF]  

Original Contributions
Kinin B₁ Receptor Expression on Multiple Sclerosis Mononuclear Cells: Correlation With Magnetic Resonance Imaging T2-Weighted Lesion Volume and Clinical Disability

Alexandre Prat; Katarzyna Biernacki; Tanya Saroli; John E. Orav; Charles R. G. Guttmann; Howard L. Weiner; Samia J. Khoury; Jack P. Antel
Arch Neurol 2005; 62: 795-800. [Abstract] [Full text] [PDF]  

Original Contributions
Diffusion-Tensor Magnetic Resonance Imaging Detects Normal-Appearing White Matter Damage Unrelated to Short-term Disease Activity in Patients at the Earliest Clinical Stage of Multiple Sclerosis

Antonio Gallo; Marco Rovaris; Roberto Riva; Angelo Ghezzi; Beatrice Benedetti; Vittorio Martinelli; Andrea Falini; Giancarlo Comi; Massimo Filippi
Arch Neurol 2005; 62: 803-808. [Abstract] [Full text] [PDF]  

Original Contributions
Interferon Beta Promotes Nerve Growth Factor Secretion Early in the Course of Multiple Sclerosis

Katarzyna Biernacki; Jack P. Antel; Manon Blain; Sridar Narayanan; Douglas L. Arnold; Alexandre Prat
Arch Neurol 2005; 62: 563-568. [Abstract] [Full text] [PDF]  

Original Contributions
Metabolite Changes in Normal-Appearing Gray and White Matter Are Linked With Disability in Early Primary Progressive Multiple Sclerosis

J. Sastre-Garriga; G. T. Ingle; D. T. Chard; Lí. Ramió-Torrentà; M. A. McLean; D. H. Miller; A. J. Thompson
Arch Neurol 2005; 62: 569-573. [Abstract] [Full text] [PDF]  

Original Contributions
Early Differential Diagnosis of Multiple Sclerosis Using a New Oligoclonal Band Test

Luisa M. Villar; Jaime Masjuan; María C. Sádaba; Pedro González-Porqué; José Plaza; Alfredo Bootello; José C. Álvarez-Cermeño
Arch Neurol 2005; 62: 574-577. [Abstract] [Full text] [PDF]  

Original Contributions
Progressive Gray Matter Damage in Patients With Relapsing-Remitting Multiple Sclerosis: A Longitudinal Diffusion Tensor Magnetic Resonance Imaging Study

Celia Oreja-Guevara; Marco Rovaris; Giuseppe Iannucci; Paola Valsasina; Domenico Caputo; Rosella Cavarretta; Maria Pia Sormani; Pasquale Ferrante; Giancarlo Comi; Massimo Filippi
Arch Neurol 2005; 62: 578-584. [Abstract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33